Sexual Dimorphism in Cardiovascular Biomarkers: Clinical and Research Implications.
Sex-based differences in cardiovascular disease presentation, diagnosis, and response to therapies are well established, but mechanistic understanding and translation to clinical applications are limited. Blood-based biomarkers have become an important tool for interrogating biologic pathways. Understanding sexual dimorphism in the relationship between biomarkers and cardiovascular disease will enhance our insights into cardiovascular disease pathogenesis in women, with potential to translate to improved individualized care for men and women with or at risk for cardiovascular disease. In this review, we examine how biologic sex associates with differential levels of blood-based biomarkers and influences the effect of biomarkers on disease outcomes. We further summarize key differences in blood-based cardiovascular biomarkers along central biologic pathways, including myocardial stretch/injury, inflammation, adipose tissue metabolism, and fibrosis pathways in men versus women. Finally, we present recommendations for leveraging our current knowledge of sex differences in blood-based biomarkers for future research and clinical innovation.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
DOI
EISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- Sex Characteristics
- Risk Factors
- Inflammation Mediators
- Humans
- Cardiovascular System & Hematology
- Cardiovascular Diseases
- Biomarkers
- Adipose Tissue
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
Citation
Published In
DOI
EISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- Sex Characteristics
- Risk Factors
- Inflammation Mediators
- Humans
- Cardiovascular System & Hematology
- Cardiovascular Diseases
- Biomarkers
- Adipose Tissue
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology